https://www.selleckchem.com/pr....oducts/ly2780301.htm
001). The pre-ETROP group who were treated with laser LIO alone had 100% regression, while the ETROP group who were treated with LIO (26 eyes) had 88.46% regression. There were 2 eyes of this group who were treated with a combination of LIO and IVT Bevacizumab. Both of them did not have regression. The recurrence of ROP requiring retreatment occurred in 2 eyes (7.14%) of the ETROP group, but no recurrence in the pre-ETROP group ( =0.092). The progression after treatment occurred in 3 eyes (10.71%) in the ETROP group, but no progressio